#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Marginal zone lymphoma refractory Retinopathy proliferative Leukocyte adhesion deficiency Primary immunodeficiency syndrome Basal cell naevus syndrome Cerebellar ataxia Soft tissue necrosis Graft versus host disease NTRK gene fusion overexpression Spinal muscular atrophy Ewing's sarcoma Antithrombin III deficiency Severe myoclonic epilepsy of infancy Juvenile chronic myelomonocytic leukaemia Liver abscess More trials…

    Learn about Rare Diseases

    Myelodysplastic syndrome – Trials in Disease Methylmalonic acidaemia – Diagnostics Langerhans’ cell histiocytosis – Basic Information Gaucher’s disease type III – Diagnostics Congenital hypotransferrinaemia – Treatment Haemophilia B with anti factor IX – Diagnostics Andersen-Tawil syndrome Hereditary ataxia – Life with Disease Usher’s syndrome – Trials in Disease Medulloblastoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Xenon Phosphocreatine Sodium ZINC CHLORIDE Metamizole Magnesium Aon-D21 Acenocoumarol Ioversol Mirikizumab AZD1163 Grwd5769 Zilucoplan Sodium Sodium Lactate Fosamprenavir Calcium ARI0008 Azd5462 Degarelix Iclepertin Nimorazole Leriglitazone Keto-Valine Calcium More therapies…

    Learn about Your Condition

    Persistent depressive disorder Leiomyosarcoma recurrent Embolism venous Lung neoplasm malignant Fibrosarcoma metastatic Undifferentiated sarcoma Laparoscopic surgery Corneal graft rejection Epiphysiolysis Migraine with aura Post procedural infection Lung transplant Rectal neoplasm Phenylketonuria Graft versus host disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut de Cancérologie Hématologie Universitaire…

Institut de Cancérologie Hématologie Universitaire de Saint Etienne (iCHUSE)

Avenue Albert Raimond, Saint Priest En Jarez, 42270, France

Want to learn more about this study or check if you can participate? Contact us.

  • Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis

    Recruiting

    2 1
    Investigated Drugs:
    • SPY002
    Austria Belgium Bulgaria Croatia Czechia France +9

  • Efficacy and safety of sarilumab plus prednisone versus prednisone alone in adults with early polymyalgia rheumatica

    Recruiting

    3 1 1
    Investigated Drugs:
    • Sarilumab
    • Prednisone
    Austria Belgium Czechia France Germany Greece +3

  • Efficacy of high- and low-dose psilocybin in preventing relapse in adults with severe alcohol use disorder and depressive symptoms after detoxification

    Recruiting

    3 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Psilocybine
    France

  • Study of pelabresib (DAK539) plus ruxolitinib versus placebo plus ruxolitinib in adult patients with myelofibrosis who are JAK‑inhibitor‑naive

    Recruiting

    3 1 1
    Investigated Diseases:
    • Primary myelofibrosis
    • Myelofibrosis
    Investigated Drugs:
    • 2-((4S)-6-(4-Chlorophenyl)-1-Methyl-4H-Benzo[C]Isoxazolo[4,5-E]Azepin-4-Yl)Acetamide Monohydrate
    • Ruxolitinib
    Austria Belgium Czechia France Germany Italy +3

  • Study of TYRA-300 in Adults with Low Grade Upper Tract Urothelial Carcinoma to Assess Efficacy and Safety

    Recruiting

    2 1 1
    Investigated Diseases:
    • Transitional cell carcinoma
    Investigated Drugs:
    • Tyra-300-B01
    Bulgaria France Spain

  • INCA33890 With Standard Chemotherapy and Bevacizumab in First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Bevacizumab
    • Calcium Folinate
    • Fluorouracil
    Austria Belgium Denmark France Germany Italy +4

  • QTX-2101 and Arsenic Trioxide in Adult Patients With Acute Promyelocytic Leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute promyelocytic leukaemia
    Investigated Drugs:
    • Arsenic Trioxide
    France Germany Italy Poland Romania Spain

  • Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis

    Recruiting

    3 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Zasocitinib
    Belgium Bulgaria Croatia Czechia Estonia France +7

  • Cenegermin Eye Drops for Persistent Corneal Epithelial Defect in Patients with Persistent Corneal Epithelial Defect

    Recruiting

    3 1 1
    Investigated Diseases:
    • Persistent corneal epithelial defect
    Investigated Drugs:
    • Cenegermin
    • Oxybuprocaine Hydrochloride
    • Tetracaine Hydrochloride
    Czechia France Germany Hungary Italy The Netherlands +2

  • Belzutifan and Zanzalintinib in Adults with Advanced Renal Cell Carcinoma After PD-1/L1 and VEGF-TKI Therapy

    Recruiting

    3 1 1
    Investigated Drugs:
    • N-(4-Fluorophenyl)-N-(4-((7-Methoxy-6-(Methylcarbamoyl)Quinolin-4- Yl)Oxy)Phenyl)Cyclopropane-1,1-Dicarboxamide
    • Belzutifan
    Czechia Denmark France Germany Greece Italy +3
Previous Page
1 2 3 4 … 46
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!